Michel is a partner for M&A in Life Sciences and Healthcare at Deloitte Switzerland. Michel has more than 15 years of experience in the Pharmaceutical and Consumer Care industries. He has been leading strategy initiatives and M&A mandates including acquisition and divestiture of businesses, product portfolios and manufacturing units for Swiss and global companies in Europe, the US and emerging markets.
Clients value Michel’s industry expertise, from regulatory issues or contract manufacturing (CDMO) topics to commercial go to market strategies, his broad network and cross-border transaction experience.